|
Biotage AB - Comparative Business Analysis Snapshot
Business Description
Biotage AB. The Group's principal activities are to provide complete solutions, knowledge and experience in the areas of genetic analysis and medicinal chemistry. The operations are carried out through two segments; Biosystems and Discovery Chemistry. Biosystems develops, produces and markets systems for fast and accurate genetic analysis based on the Group's patented technology, Pyrosequencing TM, a method for DNA sequencing. Biosystems technology helps the genetic researcher to increase knowledge of the genetic make-up of humans and organisms. Furthermore Biosystems provides an extensive software for the Biotage purification system. Discovery Chemistry develops, manufactures and markets systems, knowledge products and consumables that speed up the medicinal chemist's possibilities to develop new active substances that become the medicines of the future. The Company has sales offices and distribution partners in Europe, Japan, the United States and Rest of the World.
Competitor Analysis
This analysis compares Biotage AB with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
